Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126457801 | 12645780 | 1 | I | 20151117 | 20160811 | 20160811 | PER | US-ENDO PHARMACEUTICALS INC.-2015-004378 | ENDO | 0.00 | M | Y | 82.17000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126457801 | 12645780 | 1 | PS | PREDNISONE TABLETS | PREDNISONE | 1 | Unknown | N | 40256 | TABLETS | |||||||||
| 126457801 | 12645780 | 2 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 126457801 | 12645780 | 3 | C | VITAMINS NOS | VITAMINS | 1 | 0 | ||||||||||||
| 126457801 | 12645780 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126457801 | 12645780 | 1 | Product used for unknown indication |
| 126457801 | 12645780 | 2 | Product used for unknown indication |
| 126457801 | 12645780 | 3 | Product used for unknown indication |
| 126457801 | 12645780 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126457801 | 12645780 | Laceration | |
| 126457801 | 12645780 | Skin atrophy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |